Skip to content

Clinical trials

Observational Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Observational Clear all

250 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20041
20052
20064
20077
20086
20094
20102
20118
201211
20135
201411
20158
201611
201715
201824
201913
20206
202114
202225
202313
202414
202527
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Unknown status55
Recruiting27
Not yet recruiting15
Active, not recruiting11
Terminated10
Withdrawn5
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Association for Innovation and Biomedical Research on Light and Image15
National Eye Institute (NEI)10
Assiut University6
Zhongshan Ophthalmic Center, Sun Yat-sen University6
Digital Diagnostics, Inc.5
Hospital Juarez de Mexico5
Bayer4
Eyenuk, Inc.4
Regeneron Pharmaceuticals4
University of Alabama at Birmingham4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy250
Macular Degeneration47
Diabetes Mellitus43
Retinal Diseases24
Retinal Vein Occlusion18
Glaucoma17
Diabetes Mellitus, Type 215
Macular Edema12
Cataract9
Diabetes Mellitus, Type 19

Trials

Showing 76 to 100 of 250. Each trial links to its page on Pharma Observatory.

150 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.